Editorial Staff

Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

/in , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute’s Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.

Guest:

Hannah Mamuszka is Founder & CEO of ALVA10, a healthcare technology firm. Hannah has spent her 20+ year career in diagnostics – both in pharma and at diagnostics companies, in the lab and on the business side. She believes that the challenges of diagnostic technology fully impacting patient care are more commercial than technical, and conceived of ALVA10 to create a mechanism to pull technology into healthcare by aligning incentives through data. She regularly speaks on issues regarding advancement of technology in healthcare, is on the Board of Directors for two diagnostic companies and writes a column on the value of diagnostics for the Journal of Precision Medicine.

Guest Host:

Dr. William S. Smith is Pioneer’s Visiting Fellow in the Life Sciences. Dr. Smith has 25 years of experience in government and in corporate roles. His career includes senior staff positions for the Republican House leadership on Capitol Hill, the White House Office of National Drug Control Policy, and the Massachusetts Governor’s office where he served under Governors Weld and Cellucci. He spent ten years at Pfizer Inc as Vice President of Public Affairs and Policy where he was responsible for Pfizer’s corporate strategies for the U.S. policy environment. He later served as a consultant to major pharmaceutical, biotechnology and medical device companies. Dr. Smith earned his PhD in political science with distinction at The Catholic University of America.

Get new episodes of Hubwonk in your inbox!

Recent episodes:

Learning From California: Policy Lessons From Golden State Exodus

Joe Selvaggi speaks with Tim Anaya of the Pacific Research Institute about his new book, The California Left Coast Survivor’s Guide, exploring insights and lessons on how Massachusetts can stay competitive.

New England Short Circuit: Distorted Incentives Drive Energy Prices Up and Reliability Down

Joe Selvaggi talks with Travis Fisher from the Cato Institute about the rising costs and increasing fragility of the New England power grid, as green capacity incentives distract from neglected infrastructure.

Controlling Drug Prices: Costs and Benefits of Direct Negotiation with Big Pharma

Joe Selvaggi talks with Bill Smith, Director of the Life Sciences Initiative at Pioneer Institute, about the Inflation Reduction Act’s impact on drug pricing negotiations and its potential effects on drug development, consumers, and taxpayers.

Harris’ Tax Vision: Policy & Politics

Joe Selvaggi talks with Tax Foundation Vice President William McBride about the details and potential effects of the tax policy proposed by Kamala Harris's presidential campaign

Digital Privacy Divide: Can Law Enforcement Google Where You’ve Been?

Joe Selvaggi talks with Cato Institute legal fellow Brent Skorup about the split in the court of appeals over the Constitution's 4th Amendment protections concerning law enforcement's search of location tracking data.

Housing Bond Bill: Could Billions Better Bay State Cost of Living

Joe Selvaggi talks with Pioneer's Senior Housing Fellow, Andrew Mikula, about the recently passed $5.2 billion bond bill, discussing its key features and how it might impact the supply and cost of homes in Massachusetts.

Ruinous Red Tape: Epic Cost of Unchecked Federal Rule Making

Joe Selvaggi discusses the emergence of the massive, costly, and rapidly growing register of federal rules and regulations with Competitive Enterprise Institute’s Wayne Crews.

Property Tax Reassessment: Beleaguered Buildings Bear Burden of Boston’s Burgeoning Budget

Joe Selvaggi talks with Marty Walz, the interim president of the Boston Municipal Research Bureau, about more viable, long-term alternatives to Mayor Wu’s property tax classification proposal.

Registering Republican Realignment: GOP Convention Showcases Conservatism’s New Direction

Joe Selvaggi talks with the CATO Institute’s Dr. Norbert Michel about the shift in the Republican vision and policy goals from decades past, as reflected in the nominees and guest speakers at the 2024 GOP Convention.

Candidate Selection Breakdown: Presidential Primary Primacy or Determined Delegate Detour

Joe Selvaggi talks with MIT Professor Charles Stewart III about the political party’s presidential candidate nomination process and what or who ultimately decides who is chosen.